Arylhydroxamates are a class of organic compounds characterized by the presence of an aryl group attached to a hydroxamic acid moiety. These molecules exhibit diverse biological activities, making them valuable tools in both academic research and pharmaceutical development. Arylhydroxamates can act as metal chelators, particularly effective with transition metals such as iron or zinc, due to their ability to form stable complexes through the hydroxamate group. They are widely studied for their potential use in treating various diseases, including cancer, by disrupting iron-dependent processes within cells. Furthermore, arylhydroxamates have shown promising results in anti-inflammatory and antimicrobial applications. Their structural flexibility allows for the synthesis of derivatives with tailored properties, enhancing their utility across multiple biomedical fields.